- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03929263
Parent-Adolescent Training on Neurofeedback and Synchrony
June 25, 2021 updated by: Oklahoma State University Center for Health Sciences
The Dyadic Inter-Brain Signaling (DIBS) Project With Parent-Adolescent Training on Neurofeedback and Synchrony
The study will test a real-time functional magnetic resonance imaging (fMRI) hyperscanning neurofeedback protocol for feasibility with ten mothers and their psychiatrically healthy adolescent daughters, with the eventual goal to test this in a sample of depressed adolescents in a future study.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
This study will utilize a rigorous multi-method, multi-informant design to examine the effects of dyadic neurofeedback (dnf) on adolescent brain activation with fMRI hyperscanning.
Parents and adolescents will also report on emotion regulation, depressive symptoms, and parenting practices.
Data collection procedures will take place at the Laureate Institute for Brain Research (LIBR), which is equipped with two identical scanners that have advanced real-time fMRI systems capable of conducting parallel fMRI hyperscanning, including the capacity for neurofeedback.
Parents will complete a phone screen to determine initial eligibility.
If initial study criteria are met, a 2-hour in-person lab visit will be scheduled where mothers and daughters will complete consent/assent; diagnostic interviews; surveys on emotion regulation, parenting practices, depression, and anxiety; and additional screening.
Survey data will be used for preliminary exploratory analyses.
Based on data collected from the screening visit, participants will be invited to participate in the full study: a 4-hour visit where mothers and daughters will complete emotion ratings, mock scanner training, and fMRI tasks individually and together using hyperscanning (scan time = 16 min resting-state [2 runs], 7 min structural MRI, 40 min fMRI tasks, 10 min clinical MRI scans).
Study Type
Interventional
Enrollment (Actual)
42
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Oklahoma
-
Tulsa, Oklahoma, United States, 74136
- Laureate Institute for Brain Research
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
13 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Eligible for fMRI
- Sufficient English fluency to complete tasks
- BMI ≦ 40.0
- Right-handed
- Biological female
- Co-residing at least 4 days/week
- Adult participants: Biological mother of adolescent participant
- Adult participants:Primary caregiver > 50% of child's lifespan
- Adult participants:BMI ≧ 18.0
- Adolescent participants: Age 13-17 years
- Adolescent participants: BMI ≧ 16.0
Exclusion Criteria:
- Current psychiatric diagnosis
- Medications influencing fMRI
- Medical conditions influencing fMRI
- Alcohol or psychoactive drug on scan day
- Adolescent participants: Neurodevelopmental delay
- Adolescent participants: History of mood or psychotic disorder
- Adolescent participants: History of obsessive-compulsive disorder (OCD) or attention-deficit/hyperactivity disorder (ADHD)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Real-time fMRI neurofeedback
All participants will receive neurofeedback from the target region (no sham condition).
|
Participants will attempt to regulate own and/or their partner's brain activation in a specified brain region via real-time fMRI neurofeedback.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Neurofeedback Rating Scale
Time Frame: Baseline (Acquired during scan session)
|
Rating scale of perceived effectiveness in completing the task and changing brain activation.
Likert scale ranging from 0-10, with higher numbers indicating greater perceived effectiveness.
|
Baseline (Acquired during scan session)
|
Emotion Rating Scale
Time Frame: Baseline (Acquired during scan session)
|
Rating scale asking about current experience of various emotions (happy, sad, angry, etc.).
Scale ranges from 0-10, with higher numbers indicating more intense emotions.
|
Baseline (Acquired during scan session)
|
Blood Oxygen Level-Dependent (BOLD) Signal Changes (Brain Activation)
Time Frame: Baseline (Acquired during scan session)
|
Activation in the brain region targeted for neurofeedback and associated regions; resting-state network activity
|
Baseline (Acquired during scan session)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 25, 2019
Primary Completion (Actual)
February 27, 2021
Study Completion (Actual)
February 27, 2021
Study Registration Dates
First Submitted
April 22, 2019
First Submitted That Met QC Criteria
April 25, 2019
First Posted (Actual)
April 26, 2019
Study Record Updates
Last Update Posted (Actual)
June 29, 2021
Last Update Submitted That Met QC Criteria
June 25, 2021
Last Verified
June 1, 2021
More Information
Terms related to this study
Other Study ID Numbers
- CHS2017011
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Testing Protocol With Healthy Individuals for Feasibility
-
University of LahoreCompleted
-
The Cleveland ClinicGeneral ElectricCompletedHealthy Individuals With Perceived StressUnited States
-
Yonsei UniversityNot yet recruitingHealthy Elderly Individuals With High LDL-cholesterol or Risk of Cardiovascular DiseaseKorea, Republic of
-
Universitaire Ziekenhuizen KU LeuvenCompleted
-
Glostrup University Hospital, CopenhagenUnknownHealthy Individuals | Patients With Diabetes.Denmark
-
Fondazione Golgi CenciUniversity of Pavia; Mario Negri Institute for Pharmacological Research; Alzheimer... and other collaboratorsCompletedMild Cognitive Impairment | Healthy Subjects With Family History for DementiaItaly
-
Vanderbilt University Medical CenterRecruitingIdiopathic Pulmonary Arterial Hypertension | Heritable Pulmonary Arterial Hypertension | Unaffected Mutation Carriers: Healthy Participants With a Known BMPR2 Gene Mutation and Normal Pulmonary Pressure and RV Function on Echo | Healthy Individuals With no Cardiopulmonary DiseaseUnited States
Clinical Trials on Real-time fMRI neurofeedback
-
University of PittsburghCompleted
-
Laureate Institute for Brain Research, Inc.National Institute of Mental Health (NIMH)CompletedMajor Depressive DisorderUnited States
-
University of Electronic Science and Technology...Completed
-
Yale UniversityCentral Institute of Mental Health, Mannheim; AE FoundationCompletedBorderline Personality DisorderUnited States
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingBipolar Disorder
-
Columbia UniversityNational Institute of Mental Health (NIMH)RecruitingRumination | Depression in AdolescenceUnited States
-
Oklahoma State University Center for Health SciencesOklahoma State UniversityCompletedEmotional Dysfunction | Early Life StressUnited States
-
University of BernUniversity of ZurichActive, not recruiting
-
Kessler FoundationRecruitingStroke | Dyslexia, AcquiredUnited States